ArticleSignal transduction and targeted therapy2022

MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling.

Qiushuo Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.